EGAN CFO Form 4: 5,000 options at $2.5, 5,000 shares sold
Rhea-AI Filing Summary
eGain (EGAN) insider activity: the Chief Financial Officer reported Form 4 transactions on 11/03/2025. He exercised 5,000 stock options at $2.5 and sold 5,000 common shares at an average price of $14.44 pursuant to a Rule 10b5-1 plan adopted on March 8, 2024.
After these trades, he directly holds 129,187 common shares and 38,000 stock options remain beneficially owned. The reported sales were executed across multiple trades between $14.23 and $14.74.
Positive
- None.
Negative
- None.
Insights
Routine Form 4: option exercise and matched sale under 10b5-1.
The CFO exercised 5,000 options at $2.5 and sold 5,000 shares at a reported average of $14.44 on 11/03/2025. The filing notes execution under a Rule 10b5-1 trading plan adopted on March 8, 2024, indicating a pre-set schedule.
Post-transaction, direct holdings are 129,187 shares, with 38,000 options remaining. The sale price range was $14.23–$14.74. This appears administrative and does not, by itself, alter the company’s fundamentals.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 5,000 | $0.00 | -- |
| Exercise | Common Stock | 5,000 | $2.50 | $13K |
| Sale | Common Stock | 5,000 | $14.44 | $72K |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024. Represents actual price. These shares were sold in multiple transactions ranging in price from $14.23 to $14.74. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The options, representing a right to purchase a total of 112,000 shares, became exercisable beginning on September 19, 2017, and is now fully vested.